These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2873471)
61. How have developments in molecular imaging techniques furthered schizophrenia research? Thompson JL; Urban N; Abi-Dargham A Imaging Med; 2009 Dec; 1(2):135-153. PubMed ID: 21243081 [TBL] [Abstract][Full Text] [Related]
62. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems. Hirvonen J; Hietala J CNS Neurosci Ther; 2011 Apr; 17(2):89-96. PubMed ID: 21199447 [TBL] [Abstract][Full Text] [Related]
63. Facilins, a novel class of biological factors that facilitate the aortic response to dopamine and other biogenic amines. Silvestrini B; Palmery M; Tolu L; Basta F; Leone MG; Cheng CY J Neural Transm Gen Sect; 1994; 95(2):77-93. PubMed ID: 7865170 [TBL] [Abstract][Full Text] [Related]
64. The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system. Ohuoha DC; Hyde TM; Kleinman JE Psychopharmacology (Berl); 1993; 112(1 Suppl):S5-15. PubMed ID: 7831440 [TBL] [Abstract][Full Text] [Related]
65. Reduced visuospatial performance in children with the D2 dopamine receptor A1 allele. Berman SM; Noble EP Behav Genet; 1995 Jan; 25(1):45-58. PubMed ID: 7755518 [TBL] [Abstract][Full Text] [Related]
66. The ageing brain, neuroleptic drugs and the enigma of schizophrenia. Waddington JL Ir J Med Sci; 1988 May; 157(5):135-41. PubMed ID: 2906348 [No Abstract] [Full Text] [Related]
67. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Baker GB; Greenshaw AJ Cell Mol Neurobiol; 1989 Mar; 9(1):1-44. PubMed ID: 2565769 [TBL] [Abstract][Full Text] [Related]
68. Where have we got to with neuroreceptor mapping of the human brain? Mazière B; Mazière M Eur J Nucl Med; 1990; 16(11):817-35. PubMed ID: 2170141 [TBL] [Abstract][Full Text] [Related]
69. Structural and functional brain imaging in schizophrenia. Cleghorn JM; Zipursky RB; List SJ J Psychiatry Neurosci; 1991 Jul; 16(2):53-74. PubMed ID: 1911736 [TBL] [Abstract][Full Text] [Related]
70. Radiobrominated spiroperidol for the study of dopamine D2 receptors. De Jesus OT; Friedman AM Int J Rad Appl Instrum A; 1986; 37(8):719-26. PubMed ID: 3021673 [TBL] [Abstract][Full Text] [Related]
71. Brain dopamine receptors in schizophrenia: PET problems. Seeman P Arch Gen Psychiatry; 1988 Jun; 45(6):598-600. PubMed ID: 3259865 [No Abstract] [Full Text] [Related]
72. Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease. Laihinen A; Rinne JO; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK Acta Radiol Suppl; 1991; 376():151. PubMed ID: 1666759 [No Abstract] [Full Text] [Related]
73. Positron tomography of a radio-brominated analog of the D1/DA1 antagonist, SCH 23390. Friedman AM; DeJesus OT; Woolverton WL; van Moffaert G; Goldberg LI; Prasad A; Barnett A; Dinerstein RJ Eur J Pharmacol; 1985 Feb; 108(3):327-8. PubMed ID: 3886409 [No Abstract] [Full Text] [Related]
74. Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients. Sedvall G; Farde L; Wiesel FA Life Sci; 1987 Aug; 41(7):813-6. PubMed ID: 2956473 [No Abstract] [Full Text] [Related]